Skip to content

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here. Hide this message

Your visit

Patient Information Leaflets

Use the menu to find patient information leaflets for a specific department or service.


Other information leaflets

About the consent form - This leaflet explains what consent is and aims to answer any questions you may have.

Blood transfusion - Information for patients following a blood transfusion

Clinical Biochemistry - Information and advice about collection of blood, urine and stool samples

John's Campaign - This leaflet aims to help family or friends who usually care for a loved one with dementia to continue doing so if they are in hospital.

Overcoming nicotine addiction - taking the first step

Pressure ulcer and treatment

Preventing blood clots (Venous Thromboembolism) when you are in hospital

Preventing blood clots (Venous Thromboembolism) when you had a lower limb injury

Seasonal Influenza (Flu) 

Your Experiences Matter
Easy Read version of Your Experiences Matter
How to say thank you, make a comment, get an answer to a concern or make a formal complaint

If you have any queries or comments about this section of the website, please contact our patient experience team

Internal hospital signage with arrows to Main Reception, Outpatients and Pharmacy

A-Z of Services

Looking down a long bright hospital corridor with treatment rooms on the left and windows on the right. At the bottom of the corridor is one member of staff in a blue nursing uniform

Our Hospitals

Chinese Poland

View all languages >

Visiting update

To protect our patients, staff, visitors and the community, we are again restricting visitors to all our hospitals sites so please read our latest guidance for full details before coming to our hospitals.

The decision to restrict visitors during this time has been very difficult and made only after careful consideration as we witness wider social restrictions to prevent the spread of COVID-19 in light of the highly transmissible OMICRON variant.  The guidance will be reviewed regularly.